DrugCite
Search

CAMPRAL

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Campral Adverse Events Reported to the FDA Over Time

How are Campral adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Campral, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Campral is flagged as the suspect drug causing the adverse event.

Most Common Campral Adverse Events Reported to the FDA

What are the most common Campral adverse events reported to the FDA?

Diarrhoea
44 (2.72%)
Fall
21 (1.3%)
Vomiting
20 (1.24%)
Drug Interaction
18 (1.11%)
Nausea
18 (1.11%)
Suicide Attempt
18 (1.11%)
Depression
16 (.99%)
Blood Glucose Increased
15 (.93%)
Foetal Alcohol Syndrome
15 (.93%)
Somnolence
15 (.93%)
Dizziness
14 (.86%)
Show More Show More
Flatulence
13 (.8%)
Haemoglobin Decreased
13 (.8%)
Drug Ineffective
12 (.74%)
Headache
12 (.74%)
Pollakiuria
12 (.74%)
Amnesia
11 (.68%)
Cytolytic Hepatitis
11 (.68%)
Drug Exposure During Pregnancy
11 (.68%)
Dysarthria
11 (.68%)
Insomnia
11 (.68%)
Pruritus
11 (.68%)
Renal Failure
11 (.68%)
Abdominal Pain
10 (.62%)
Alcoholism
10 (.62%)
Anxiety
10 (.62%)
Aspartate Aminotransferase Increase...
10 (.62%)
Asthenia
10 (.62%)
Blood Sodium Decreased
10 (.62%)
Confusional State
10 (.62%)
Decreased Appetite
10 (.62%)
Drug Screen False Positive
10 (.62%)
Metabolic Acidosis
10 (.62%)
Tachycardia
10 (.62%)
Renal Failure Acute
9 (.56%)
Tremor
9 (.56%)
Agitation
8 (.49%)
Arthralgia
8 (.49%)
Catatonia
8 (.49%)
Condition Aggravated
8 (.49%)
Fatigue
8 (.49%)
Gait Disturbance
8 (.49%)
Malaise
8 (.49%)
Maternal Drugs Affecting Foetus
8 (.49%)
Abnormal Behaviour
7 (.43%)
Aggression
7 (.43%)
Blood Bilirubin Increased
7 (.43%)
Coma
7 (.43%)
Disorientation
7 (.43%)
Dyspnoea
7 (.43%)
Encephalopathy
7 (.43%)
Gamma-glutamyltransferase Increased
7 (.43%)
International Normalised Ratio Incr...
7 (.43%)
Jaundice
7 (.43%)
Neutrophil Count Increased
7 (.43%)
Rash Pruritic
7 (.43%)
Suicidal Ideation
7 (.43%)
Vision Blurred
7 (.43%)
Alanine Aminotransferase Increased
6 (.37%)
Alcohol Use
6 (.37%)
Anorgasmia
6 (.37%)
Cleft Palate
6 (.37%)
Completed Suicide
6 (.37%)
Coordination Abnormal
6 (.37%)
Dysmorphism
6 (.37%)
Hepatitis Fulminant
6 (.37%)
Hypersensitivity
6 (.37%)
Intentional Drug Misuse
6 (.37%)
Intentional Overdose
6 (.37%)
Multiple Drug Overdose Intentional
6 (.37%)
Thirst
6 (.37%)
Thrombocytopenia
6 (.37%)
Urticaria
6 (.37%)
Weight Decreased
6 (.37%)
Weight Increased
6 (.37%)
Abdominal Distension
5 (.31%)
Abdominal Pain Upper
5 (.31%)
Alcohol Poisoning
5 (.31%)
Ammonia Increased
5 (.31%)
Ascites
5 (.31%)
Blood Pressure Increased
5 (.31%)
Cholelithiasis
5 (.31%)
Convulsion
5 (.31%)
Deafness Neurosensory
5 (.31%)
Dehydration
5 (.31%)
Dermatitis Exfoliative
5 (.31%)
Dialysis
5 (.31%)
Drug Toxicity
5 (.31%)
Dry Mouth
5 (.31%)
Erythema
5 (.31%)
Hepatic Cirrhosis
5 (.31%)
Hepatic Failure
5 (.31%)
Hepatitis
5 (.31%)
Hepatocellular Injury
5 (.31%)
Hypoglycaemia
5 (.31%)
Loss Of Consciousness
5 (.31%)
Mydriasis
5 (.31%)
Nervousness
5 (.31%)
Rash
5 (.31%)
Treatment Noncompliance
5 (.31%)
White Blood Cell Count Decreased
5 (.31%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Campral, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Campral is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Campral

What are the most common Campral adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Campral, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Campral is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Campral According to Those Reporting Adverse Events

Why are people taking Campral, according to those reporting adverse events to the FDA?

Alcoholism
275
Abstains From Alcohol
22
Alcohol Abuse
19
Drug Use For Unknown Indication
15
Alcohol Use
14
Alcohol Detoxification
10
Show More Show More
Product Used For Unknown Indication
8
Alcohol Withdrawal Syndrome
7
Prophylaxis
6
Alcohol Rehabilitation
5
Alcohol Poisoning
4
Prophylaxis Against Alcoholic Withd...
3
Weight Decreased
2
Alcohol Problem
2
Obsessive-compulsive Disorder
2
Bipolar Ii Disorder
2
Nicotine Dependence
1
Arthralgia
1
Smoking Cessation Therapy
1
Drug Abuser
1
Tinnitus
1
Abdominal Pain Upper
1
Suicide Attempt
1
Drug Dependence
1
Anxiety
1
Convulsion
1
Overdose
1
Neuralgia
1
Impulse-control Disorder
1
Self Injurious Behaviour
1
Therapy Cessation
1
Hepatic Cirrhosis
1
Drug Withdrawal Maintenance Therapy
1
Gastric Disorder
1

Drug Labels

LabelLabelerEffective
Campral Forest Laboratories, Inc. 31-JAN-12

Campral Case Reports

What Campral safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Campral. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Campral.